PROMOEXQ
LIVE

Serial Number

79400739

Owner

PromoCell GmbH

Attorney

Shoko Naruo

Filing Date

Jan 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PROMOEXQ Trademark

Serial Number: 79400739 • Registration: 7846545

PROMOEXQ is a trademark filed by PromoCell GmbH on January 24, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

PromoCell GmbH (8 trademarks)

Sickingenstr. 63/65

Entity Type: 99

Trademark Details

Filing Date

January 24, 2024

Registration Date

July 1, 2025

Published for Opposition

May 13, 2025

Goods & Services

Chemical reagents and biological reagents for medical, biomedical, and veterinary purposes; biological preparations for medical, veterinary, and biomedical purposes, namely, media for bacteriological cultures for medical purposes, bacterial preparations for medical use, bacteriological preparations for medical use, bacterial preparations for veterinary purposes, media for bacteriological cultures for veterinary purposes, bacteriological preparations for veterinary use, biological tissue cultures for medical purposes, microbiological culture for medical use, nutritive substances for microorganisms, biocides for medical purposes, microbial preparations for medical use, biological reagent for medical purposes, diagnostic biomarker reagents for medical purposes, microbial preparations for veterinary purposes, biocides for veterinary purposes, microbial culture for veterinary purposes, biological tissue cultures for veterinary purposes, biological reagent for medical purposes, diagnostic test reagent for medical purposes, and reagent paper for veterinary purposes; chemical and biological articles, preparations, goods, substances, media, and reagents, all for medical, biomedical, and veterinary purposes and for use in laboratories, namely, biological reagents for medical and veterinary use, chemical reagents for medical and veterinary purposes; diagnostic reagents for medical use; cell culture media for medical and veterinary use; enzymes, growth factors, antibodies, and proteins for and medical, biomedical, and veterinary purposes for use in medical laboratories, namely, enzymes, cell culture media in the nature of human, animal and plant cells, cell culture media, biological tissue cultures, stem cells, blood culture media, cell growth media for growing cells, antibodies and protein arrays, all for medical, biomedical, and veterinary purposes as well as for use in laboratories for medical or veterinary purposes

Chemicals and biological preparations used in industry and science; biological preparations for use in industry and science; biochemical preparations for industrial and scientific purposes; chemical and biological products, preparations, substances, media, and reagents used in science and for use in laboratories and business, namely, chemical and biological preparations for industrial and scientific purposes, biological agents for industrial and scientific purposes, biochemical reagents for non-medical purposes, chemical substances for analyses in laboratories, other than for medical or veterinary use, chemical and biological substances for analyses in laboratories including medical research and veterinary research, other than for medical or veterinary purposes, chemical and biological media in the nature of cell growth media for growing cells for scientific and research use in laboratories, and chemical and biological reagents for scientific, industrial purposes as well as for use in laboratories including medical research and veterinary research, but excluding medical or veterinary purpose; enzymes, growth factors, proteins, and antibodies for use in science, laboratories, and industry, namely, enzymes, cell culture media in the nature of human, animal and plant cells, cell culture media, biological tissue cultures, stem cells, blood culture media, cell growth media for growing cells, monoclonal antibodies and proteins, all for scientific and industrial purposes as well as for use in laboratories including for medical research and veterinary research, but excluding medical or veterinary purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 28, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 28, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 8, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 1, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 9, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 9, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 9, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 9, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 9, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Mar 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Mar 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 18, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 18, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2025 COAR
REFUSAL PROCESSED BY IB
Oct 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 11, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2024 DOCK
ASSIGNED TO EXAMINER
Aug 29, 2024 DOCK
ASSIGNED TO EXAMINER
Aug 19, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 30, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR